Clostridium difficileshows no trade‐off between toxin and spore production within the human host. Issue 5 (May 2018)

• Record Type: Journal Article
• Authors: Blanco, Natalia; Walk, Seth; Malani, Anurag N.; Rickard, Alexander; Benn, Michele; Eisenberg, Marisa; Zhang, Min; Foxman, Betsy
• Is Part Of: Journal of medical microbiology. Volume 67:Issue 5(2018)
• Publication Date: 2018-05
• Subjects: Clostridium difficile infection -- toxin -- spores; Medical microbiology -- Periodicals; 616.9041
• DOI: 10.1099/jmm.0.000719
• Languages: English
• ISSNs: 0022-2615

Abstract

Abstract : Purpose. : This study aimed to describe the correlation between Clostridium difficile spore and toxin levels within the human host. In addition, we assessed whether overgrowth of Candida albicans modified this association. Methodology. : We measured toxin, spore and Candida albicans levels among 200 successively collected stool samples that tested positive for C. difficile, and PCR ribotyped these C. difficile isolates. Analysis of variance and linear regression were used to test the association between spore and toxin levels. Kruskal‐Wallis tests and t ‐tests were used to compare the association between spore or toxin levels and host, specimen, or pathogen characteristics. Results. : C. difficile toxin and spore levels were positively associated ( P <0.001); this association did not vary significantly with C. albicans overgrowth [≥5 logs of C. albicans colony‐forming units (c.f.u.) g −1 ]. However, ribotypes 027 and 078–126 were significantly associated with higher levels of toxin and spores, and C. albicans overgrowth. Conclusion. : The strong positive association observed between in vivo levels of C. difficile toxin and spores suggests that patients with more severe C. difficile infections may have increased spore production, enhancing C. difficile transmission. Although, on average, spore levels were higher in toxin‐positive samples than in toxin‐negative/PCR‐positive samples, spores were found in almost all toxin‐negative samples. The ubiquity of spore production among toxin‐negative and formed stool samples emphasizes the importance of following infection prevention and control measures for all C. difficile ‐positive patients during their entire hospital stay.